Collectively, the therapeutic effects of QKL treatment on alleviating pneumonia may be dependent on suppression of the NF-κB pathway, reduction of gene (Ccl19 and Ccl21) expression and Staphylococcus abundance. The gene discussed is NFKB1; the disease is pneumonia.